News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Launches Next Generation Medical Device to Improve Neonatal Feeding
08/30/2023

The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral feeding. 

DUBLIN, Ohio, Aug. 30, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the launch of its next generation NTrainer™ System 2.0, a medical device designed to help premature and newborn infants develop the oral coordination skills important for the transition to independent feeding faster, thus helping to reduce their neonatal intensive care unit (NICU) length of stay. Through real-time assessment technology, the NTrainer™ System provides clinicians with the objective data they need to track the progress of an infant in developing pre-feeding skills, while providing parents confidence in their infants' progress and potential to thrive after discharge.

The NTrainer™ System improves crucial key pre-feeding skills in newborns and preterm infants known as non-nutritive suck (NNS). NNS is critical for the safe transition from feeding tubes to breast or bottle — a developmental milestone for preterm infants and recommended by the American Academy of Pediatrics as criteria for discharge from the NICU. By utilizing Cardinal Health's patented technology for improving NNS proficiency, the NTrainer™ has been clinically proven to improve feeding outcomes while also reducing length of NICU stay.

"The NTrainer™ System demonstrates Cardinal Health's investment in innovation to help improve patient outcomes and increase caregiver confidence while providing objective data important for delivering consistent patient care," said Steve Mason, CEO of Cardinal Health's Medical Segment. "The NTrainer™ System will help some of our most vulnerable patients at the beginning of life through the first and only biofeedback device to improve NNS patterns in newborns and infants born prematurely."

The next generation NTrainer™ System 2.0, in comparison to the first generation NTrainer™, is smaller, more intuitive and easier to integrate into feeding protocols, while still providing consistent, repeatable assessment and therapy. It is designed to support proper suck-swallow-breathe coordination in premature infants to reduce time to achieve full oral feeding.

Cardinal Health has one of the largest healthcare medical supply chains in the U.S., with a nutritional delivery portfolio that includes the globally recognized Kangaroo™ brand, including the Kangaroo™ enteral feeding pumps and sets portfolio, the Kangaroo™ Feeding Tube with IRIS Technology, and other adult, pediatric and neonatal enteral feeding products. 

"We have a real commitment to and pride in our enteral access and nutritional delivery device portfolio. Our Kangaroo™ brand of products is an industry leader and mainstay, and our investment in the NTrainer™ System rounds out our offerings in this space," said Kelley Moffett, Senior Vice President, Global Products, Medical Segment, Cardinal Health.

For more information on the NTrainer™ System 2.0, please visit us here.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in 30 countries and approximately 46,500 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Contacts:
Media: Kristin Larsen, kristin.larsen@cardinalhealth.com, 614-757-3653

 

SOURCE Cardinal Health

More Company News
04/02/2024

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

03/26/2024

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will...

03/15/2024

Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions...

02/29/2024

Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio, Feb. 29, 2024...

View all company news »